Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.06 EUR | +1.74% | -5.13% | +43.18% |
Apr. 29 | Abivax: share price rises as two analysts express optimism | CF |
Apr. 29 | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
953M | - | |||||
47.86B | - | |||||
41.42B | ||||||
40.66B | ||||||
28.92B | ||||||
25.55B |
- Stock Market
- Equities
- ABVX Stock
- Charts Abivax
- Sector Chart